Literature DB >> 12767108

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.

Charles S Cleeland1, Gary J Bennett, Robert Dantzer, Patrick M Dougherty, Adrian J Dunn, Christina A Meyers, Andrew H Miller, Richard Payne, James M Reuben, Xin Shelley Wang, Bang-Ning Lee.   

Abstract

BACKGROUND: Cancers and cancer treatments produce multiple symptoms that collectively cause a symptom burden for patients. These symptoms include pain, wasting, fatigue, cognitive impairment, anxiety, and depression, many of which co-occur. There is growing recognition that at least some of these symptoms may share common biologic mechanisms.
METHODS: In November 2001, basic and clinical scientists met to consider evidence for a cytokine-immunologic model of symptom expression along with directions for future research.
RESULTS: The characteristics of cytokine-induced sickness behavior in animal models have much in common with those of symptomatic cancer patients. Sickness behavior refers to a set of physiologic and behavioral responses observed in animals after the administration of infectious or inflammatory agents or certain proinflammatory cytokines. In some cases, these responses can be prevented by cytokine antagonists. A combination of animal and human research suggests that several cancer-related symptoms may involve the actions of proinflammatory cytokines.
CONCLUSIONS: Based on the similarities between cancer symptoms and sickness behavior, the authors discussed approaches to further test the implications of the relationship between inflammatory cytokines and symptoms for both symptom treatment and symptom prevention. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767108     DOI: 10.1002/cncr.11382

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  172 in total

1.  Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Jean C Yi; Samantha B Artherholt; Allison C Stover; Janet R Abrams
Journal:  J Cancer Surviv       Date:  2010-05-08       Impact factor: 4.442

2.  Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy.

Authors:  Lisa K Sprod; Oxana G Palesh; Michelle C Janelsins; Luke J Peppone; Charles E Heckler; M Jacob Adams; Gary R Morrow; Karen M Mustian
Journal:  Community Oncol       Date:  2010-10

Review 3.  Translational approaches to treatment-induced symptoms in cancer patients.

Authors:  Robert Dantzer; Mary W Meagher; Charles S Cleeland
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

4.  Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer.

Authors:  Nicholas Courtier; Tina Gambling; Stephanie Enright; Peter Barrett-Lee; Jacinta Abraham; Malcolm D Mason
Journal:  Support Care Cancer       Date:  2012-05-28       Impact factor: 3.603

5.  Potential factors associated with perceived cognitive impairment in breast cancer survivors.

Authors:  Jamie S Myers; Jo A Wick; Jennifer Klemp
Journal:  Support Care Cancer       Date:  2015-04-03       Impact factor: 3.603

6.  Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling.

Authors:  Aaron J Grossberg; Elisabeth G Vichaya; Diana L Christian; Jessica M Molkentine; Daniel W Vermeer; Phillip S Gross; Paola D Vermeer; John H Lee; Robert Dantzer
Journal:  Cancer Res       Date:  2017-12-07       Impact factor: 12.701

Review 7.  The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms.

Authors:  Julienne E Bower
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

8.  A role for orexin in cytotoxic chemotherapy-induced fatigue.

Authors:  K B Weymann; L J Wood; X Zhu; D L Marks
Journal:  Brain Behav Immun       Date:  2013-11-09       Impact factor: 7.217

9.  Patient-reported outcomes in survivors of childhood hematologic malignancies with hematopoietic stem cell transplant.

Authors:  Hsiu-Ju Yen; Hesham M Eissa; Neel S Bhatt; Sujuan Huang; Matthew J Ehrhardt; Nickhill Bhakta; Kirsten K Ness; Kevin R Krull; D Kumar Srivastava; Leslie L Robison; Melissa M Hudson; I-Chan Huang
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

10.  Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.

Authors:  Debra Lyon; Lynne Elmore; Noran Aboalela; Jacqueline Merrill-Schools; Nancy McCain; Angela Starkweather; R K Elswick; Colleen Jackson-Cook
Journal:  Biol Res Nurs       Date:  2013-04-11       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.